Labeler
Amneal Pharmaceuticals LLC NDC Codes
Amneal Pharmaceuticals LLC lists 484 finished drug products in the FDA NDC Directory under NDC labeler codes 60219, 60846, 64896, 65162, 69238, 70121.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lisdexamfetamine Dimesylate, Valsartan and Hydrochlorothiazide, Lurasidone Hydrochloride, Risperidone, Crexont, Ropivacaine Hydrochloride, Pitavastatin, Pemrydi Rtu, Lyvispah, Tepadina, Methylene blue, Exenatide, calcium chloride, Ongentys, Methylprednisolone acetate
- Active ingredients
- Lisdexamfetamine dimesylate, Valsartan, Hydrochlorothiazide, Lurasidone hydrochloride, Carbidopa hydrate, Levodopa, Ropivacaine hydrochloride, Pitavastatin calcium, Pemetrexed disodium hemipentahydrate, Baclofen, Denosumab, Thiotepa
- NDC labeler codes
- 60219, 60846, 64896, 65162, 69238, 70121
- Strengths (from the 100 most recently listed products)
- Hydrochlorothiazide 12.5 mg/1; Methylene blue 5 mg/mL; Exenatide 250 ug/mL; Calcium chloride 100 mg/mL; Valsartan 160 mg/1; Hydrochlorothiazide 25 mg/1; Valsartan 320 mg/1; Medroxyprogesterone acetate 150 mg/mL; Dexmedetomidine hydrochloride 4 ug/mL; Ropivacaine hydrochloride 2 mg/mL; Ropivacaine hydrochloride 5 mg/mL; Magnesium sulfate heptahydrate 40 mg/mL; Fluorometholone 1 mg/mL; Glycopyrrolate .2 mg/mL; Lanreotide acetate 120 mg/.5mL; Romidepsin 5 mg/mL; Denosumab 70 mg/mL; Denosumab 60 mg/mL; Phytonadione 1 mg/.5mL; Epinephrine 1 mg/mL
- Dosage forms
- Injection, Injection, Solution, Tablet, Film coated, Capsule, Kit, Tablet, Extended release, Tablet, Coated, Capsule, Extended release, Injection, Suspension, Injection, Powder, Lyophilized, For solution, Granule, Tablet, Solution, Suspension/ drops, Injection, Solution, Concentrate, Injection, Emulsion, Tablet, Delayed release, Spray, For solution, Gel
- Routes
- Oral, Intravenous, Intramuscular, Subcutaneous, Epidural, Infiltration, Perineural, Intracavitary, Intravesical, Intra-articular, Intralesional, Intrasynovial, Soft tissue, Topical, Ophthalmic, Nasal
- Drug classes (FDA established)
- Central Nervous System Stimulant, Osmotic Laxative, Angiotensin 2 Receptor Blocker, Thiazide Diuretic, Atypical Antipsychotic, Aromatic Amino Acid, Corticosteroid, Amide Local Anesthetic, beta-Adrenergic Blocker, HMG-CoA Reductase Inhibitor, Potassium Salt, Anticholinergic, Cholinergic Muscarinic Antagonist, Folate Analog Metabolic Inhibitor, gamma-Aminobutyric Acid-ergic Agonist, RANK Ligand Inhibitor, Alkylating Drug, Oxidation-Reduction Agent, GLP-1 Receptor Agonist, Blood Coagulation Factor, Phosphate Binder, Catechol-O-Methyltransferase Inhibitor, Progestin, Central alpha-2 Adrenergic Agonist, Cytochrome P450 17A1 Inhibitor, Methylxanthine, Calculi Dissolution Agent, Serotonin-1b and Serotonin-1d Receptor Agonist, Somatostatin Analog, Histone Deacetylase Inhibitor, Vitamin K, Warfarin Reversal Agent, Catecholamine, alpha-Adrenergic Agonist, beta-Adrenergic Agonist, Calcitonin, Central Nervous System Depressant, Estrogen Receptor Antagonist, Ergotamine Derivative, Aminosalicylate, Tetracycline-class Drug, Cholinesterase Inhibitor, Proteasome Inhibitor, Substance P/Neurokinin-1 Receptor Antagonist, Opioid Antagonist, Pyrophosphate Analog DNA Polymerase Inhibitor, Sulfone, Hematopoietic Stem Cell Mobilizer, Nucleoside Metabolic Inhibitor, Phenothiazine, Nonsteroidal Anti-inflammatory Drug, Peroxisome Proliferator Receptor alpha Agonist
- HCPCS / J-code
- J0897 — Injection, denosumab, 1 mg, J0171 — Injection, adrenalin, epinephrine, 0.1 mg, J1040 — Injection, methylprednisolone acetate, 80 mg, J1050 — Injection, medroxyprogesterone acetate, 1 mg
- Package NDCs
- 166 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Lisdexamfetamine Dimesylatelisdexamfetamine | Lisdexamfetamine dimesylate 50 mg/1 | CapsuleOral | 65162-026 | 65162-0026-09 | — |
| Lisdexamfetamine Dimesylatelisdexamfetamine | Lisdexamfetamine dimesylate 60 mg/1 | CapsuleOral | 65162-027 | 65162-0027-09 | — |
| Lisdexamfetamine Dimesylatelisdexamfetamine | Lisdexamfetamine dimesylate 70 mg/1 | CapsuleOral | 65162-028 | 65162-0028-09 | — |
| Valsartan and Hydrochlorothiazide | Valsartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 65162-845 | 65162-0845-0365162-0845-0965162-0845-11+1 more | — |
| Valsartan and Hydrochlorothiazide | Valsartan 160 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 65162-846 | 65162-0846-0365162-0846-0965162-0846-11+1 more | — |
| Valsartan and Hydrochlorothiazide | Valsartan 160 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 65162-847 | 65162-0847-0365162-0847-0965162-0847-11+1 more | — |
| Valsartan and Hydrochlorothiazide | Valsartan 320 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 65162-848 | 65162-0848-0365162-0848-0965162-0848-11+1 more | — |
| Valsartan and Hydrochlorothiazide | Valsartan 320 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 65162-849 | 65162-0849-0365162-0849-0965162-0849-11+1 more | — |
| plerixafor | Plerixafor 24 mg/1.2mL | Injection, SolutionSubcutaneous | 70121-1694 | 70121-1694-02 | — |
| medroxyprogesterone acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | 70121-1467 | 70121-1467-0270121-1467-05 | J1050 |
| medroxyprogesterone acetate | Medroxyprogesterone acetate 150 mg/mL | Injection, SuspensionIntramuscular | 70121-1480 | 70121-1480-01 | J1050 |
| Pemrydi Rtupemetrexed disodium | Pemetrexed disodium hemipentahydrate 100 mg/10mL | InjectionIntravenous | 70121-2453 | 70121-2453-01 | — |
| Pemrydi Rtupemetrexed disodium | Pemetrexed disodium hemipentahydrate 500 mg/50mL | InjectionIntravenous | 70121-2461 | 70121-2461-01 | — |
| Pemrydi Rtupemetrexed disodium | Pemetrexed disodium hemipentahydrate 1000 mg/100mL | InjectionIntravenous | 70121-2462 | 70121-2462-01 | — |
| Lyvispahbaclofen | Baclofen 5 mg/1 | GranuleOral | 64896-076 | 64896-0076-09 | — |
| Lyvispahbaclofen | Baclofen 10 mg/1 | GranuleOral | 64896-077 | 64896-0077-09 | — |
| Lyvispahbaclofen | Baclofen 20 mg/1 | GranuleOral | 64896-078 | 64896-0078-09 | — |
| Dexmedetomidine Hydrochloridedexmedetomidine hydrochloride in sodium chloride | Dexmedetomidine hydrochloride 4 ug/mL | InjectionIntravenous | 70121-1711 | 70121-1711-0270121-1711-09 | — |
| Dexmedetomidine Hydrochloridedexmedetomidine hydrochloride in sodium chloride | Dexmedetomidine hydrochloride 4 ug/mL | InjectionIntravenous | 70121-1712 | 70121-1712-0270121-1712-03 | — |
| Abiraterone Acetateabiraterone | Abiraterone acetate 250 mg/1 | TabletOral | 60219-1165 | 60219-1165-07 | — |
| Abiraterone Acetateabiraterone | Abiraterone acetate 500 mg/1 | TabletOral | 60219-1754 | 60219-1754-06 | — |
| Nelarabine | Nelarabine 5 mg/mL | InjectionIntravenous | 70121-1743 | 70121-1743-0170121-1743-04 | — |
| theophylline | Theophylline anhydrous 300 mg/1 | Tablet, Extended releaseOral | 60219-2045 | 60219-2045-0160219-2045-0360219-2045-05+1 more | — |
| theophylline | Theophylline anhydrous 450 mg/1 | Tablet, Extended releaseOral | 60219-2046 | 60219-2046-0160219-2046-0360219-2046-05 | — |
| Ropivacaine Hydrochloride | Ropivacaine hydrochloride 2 mg/mL | InjectionEpidural, Infiltration, Perineural | 70121-1732 | 70121-1732-0370121-1732-09 | — |
| Ropivacaine Hydrochloride | Ropivacaine hydrochloride 2 mg/mL | InjectionEpidural, Infiltration, Perineural | 70121-1733 | 70121-1733-0370121-1733-09 | — |
| Ropivacaine Hydrochloride | Ropivacaine hydrochloride 5 mg/mL | InjectionEpidural, Infiltration, Perineural | 70121-1734 | 70121-1734-0370121-1734-07 | — |
| Ropivacaine Hydrochloride | Ropivacaine hydrochloride 5 mg/mL | InjectionEpidural, Infiltration, Perineural | 70121-1735 | 70121-1735-0370121-1735-07 | — |
| Magnesium Sulfatemagnesium sulfate in water for | Magnesium sulfate heptahydrate 40 mg/mL | InjectionIntravenous | 70121-1719 | 70121-1719-0270121-1719-09 | — |
| Magnesium Sulfatemagnesium sulfate in water for | Magnesium sulfate heptahydrate 40 mg/mL | InjectionIntravenous | 70121-1720 | 70121-1720-0370121-1720-09 | — |
| Zomigzolmitriptan | Zolmitriptan 2.5 mg/1 | Tablet, Film coatedOral | 60846-130 | 60846-0130-30 | — |
| Zomigzolmitriptan | Zolmitriptan 5 mg/1 | Tablet, Film coatedOral | 60846-133 | 60846-0133-60 | — |
| fluorometholone ophthalmic suspensionfluorometholone | Fluorometholone 1 mg/mL | Suspension/ dropsOphthalmic | 60219-1585 | 60219-1585-03 | — |
| fluorometholone ophthalmic suspensionfluorometholone | Fluorometholone 1 mg/mL | Suspension/ dropsOphthalmic | 60219-1586 | 60219-1586-06 | — |
| Fesoterodine Fumarate | Fesoterodine fumarate 4 mg/1 | Tablet, Extended releaseOral | 65162-369 | 65162-0369-0365162-0369-09 | — |
| Fesoterodine Fumarate | Fesoterodine fumarate 8 mg/1 | Tablet, Extended releaseOral | 65162-370 | 65162-0370-0365162-0370-09 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 20 mg/1 | Tablet, CoatedOral | 65162-879 | 65162-0879-0365162-0879-0965162-0879-50 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 40 mg/1 | Tablet, CoatedOral | 65162-880 | 65162-0880-0365162-0880-0965162-0880-50 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 80 mg/1 | Tablet, CoatedOral | 65162-881 | 65162-0881-0365162-0881-0965162-0881-50 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 120 mg/1 | Tablet, CoatedOral | 65162-882 | 65162-0882-0365162-0882-0965162-0882-50 | — |
| Lurasidone Hydrochloride | Lurasidone hydrochloride 60 mg/1 | Tablet, CoatedOral | 65162-082 | 65162-0082-0365162-0082-0965162-0082-50 | — |
| Esmolol Hydrochlorideesmolol hydrochloride in sodium chloride | Esmolol hydrochloride 10 mg/mL | InjectionIntravenous | 70121-1716 | 70121-1716-0370121-1716-07 | — |
| Esmolol Hydrochlorideesmolol hydrochloride in sodium chloride | Esmolol hydrochloride 20 mg/mL | InjectionIntravenous | 70121-1717 | 70121-1717-0370121-1717-07 | — |
| prochlorperazine edisylate | Prochlorperazine edisylate 5 mg/mL | InjectionIntramuscular, Intravenous | 70121-1580 | 70121-1580-0570121-1580-07 | — |
| leuprolide acetate | — | KitSubcutaneous | 70121-2537 | 70121-2537-06 | — |
| glycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | 70121-1698 | 70121-1698-07 | — |
| glycopyrrolate | Glycopyrrolate .2 mg/mL | Injection, SolutionIntramuscular, Intravenous | 70121-1699 | 70121-1699-07 | — |
| Diclofenac Sodiumdiclofenac | Diclofenac sodium 20 mg/g | SolutionTopical | 65162-683 | 65162-0683-12 | — |
| vasopressin | Vasopressin 20 [USP'U]/mL | InjectionIntravenous | 70121-1642 | 70121-1642-0270121-1642-0570121-1642-07 | — |
| Fenofibrate | Fenofibrate 54 mg/1 | TabletOral | 60219-5511 | 60219-5511-09 | — |
Amneal Pharmaceuticals LLC: common questions
- What is Amneal Pharmaceuticals LLC's NDC labeler code?
- 60219, 60846, 64896, 65162, 69238, 70121. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Amneal Pharmaceuticals LLC?
- Med-Code's HCPCS directory matches J0897, J0171, J1040, J1050 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.